Julia Xu

787 total citations
58 papers, 413 citations indexed

About

Julia Xu is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Julia Xu has authored 58 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 24 papers in Molecular Biology and 20 papers in Hematology. Recurrent topics in Julia Xu's work include Hemoglobinopathies and Related Disorders (29 papers), Biomedical Text Mining and Ontologies (17 papers) and Iron Metabolism and Disorders (13 papers). Julia Xu is often cited by papers focused on Hemoglobinopathies and Related Disorders (29 papers), Biomedical Text Mining and Ontologies (17 papers) and Iron Metabolism and Disorders (13 papers). Julia Xu collaborates with scholars based in United States, Spain and Canada. Julia Xu's co-authors include Kin Wah Fung, Swee Lay Thein, Olivier Bodenreider, James Geller, Douglas McCloskey, Marilyn J. Telen, Markus J. Herrgård, Yehoshua Perl, Lars Schrübbers and Hanne Bjerre Christensen and has published in prestigious journals such as Blood, CHEST Journal and BMC Public Health.

In The Last Decade

Julia Xu

50 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Xu United States 11 160 154 118 73 62 58 413
Hung S. Luu United States 10 57 0.4× 35 0.2× 102 0.9× 16 0.2× 24 0.4× 34 286
Azim Mehrvar Iran 12 44 0.3× 71 0.5× 70 0.6× 6 0.1× 19 0.3× 63 417
Sarah Sandmann Germany 11 198 1.2× 13 0.1× 27 0.2× 49 0.7× 79 1.3× 40 584
Joanna Heywood United States 10 77 0.5× 102 0.7× 80 0.7× 5 0.1× 8 0.1× 15 332
Pablo Serrano Balazote Spain 12 53 0.3× 18 0.1× 36 0.3× 68 0.9× 59 1.0× 38 344
Terrie Kitchner United States 13 139 0.9× 13 0.1× 12 0.1× 17 0.2× 30 0.5× 33 454
Jacqueline Corrigan‐Curay United States 9 135 0.8× 17 0.1× 7 0.1× 19 0.3× 32 0.5× 13 616
Brennan United States 9 67 0.4× 22 0.1× 19 0.2× 11 0.2× 11 0.2× 25 421
Jacqueline N. Milton United States 14 142 0.9× 339 2.2× 280 2.4× 2 0.0× 9 0.1× 29 600
Alex George United States 14 171 1.1× 313 2.0× 247 2.1× 12 0.2× 34 681

Countries citing papers authored by Julia Xu

Since Specialization
Citations

This map shows the geographic impact of Julia Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Xu more than expected).

Fields of papers citing papers by Julia Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Xu. The network helps show where Julia Xu may publish in the future.

Co-authorship network of co-authors of Julia Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Xu. A scholar is included among the top collaborators of Julia Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Xu. Julia Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conrey, Anna, Ingrid Frey, Julia Xu, et al.. (2025). Long-term mitapivat treatment is safe and efficacious in patients with sickle cell disease. PubMed. 1(2). 100014–100014.
2.
3.
Xu, Julia, Brian J. Philips, Jesper Petersen, et al.. (2025). Tebapivat Improves Red Cell Deformability and Decreases Sickling in Patients With Sickle Cell Disease: A Phase 1 Trial Substudy. European Journal Of Haematology. 116(1). 98–100.
6.
Xu, Julia, Enrico M. Novelli, Andreas Glenthøj, et al.. (2024). Results from a Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Tebapivat (AG-946) in Patients with Sickle Cell Disease. Blood. 144(Supplement 1). 2496–2496. 2 indexed citations
7.
Philips, Brian J., Mehdi Nouraie, Laura DeCastro, et al.. (2024). Higher Hemoglobin Level Correlates with Increased Tissue Oxygenation in a Comprehensive Profile of Hemorheology in Sickle Cell Disease. Blood. 144(Supplement 1). 294–294. 1 indexed citations
8.
Fung, Kin Wah, et al.. (2023). Mapping 3 procedure coding systems to the International Classification of Health Interventions (ICHI): coverage and challenges. Journal of the American Medical Informatics Association. 30(6). 1190–1198. 2 indexed citations
9.
Wood, Katherine C., et al.. (2023). Fatty acid nitroalkenes – Multi-target agents for the treatment of sickle cell disease. Redox Biology. 68. 102941–102941. 6 indexed citations
10.
Fung, Kin Wah, et al.. (2023). A practical strategy to use the ICD-11 for morbidity coding in the United States without a clinical modification. Journal of the American Medical Informatics Association. 30(10). 1614–1621. 3 indexed citations
12.
Schmidt, Heidi M., Evan DeVallance, Sara E. Lewis, et al.. (2023). Release of hepatic xanthine oxidase (XO) to the circulation is protective in intravascular hemolytic crisis. Redox Biology. 62. 102636–102636. 10 indexed citations
13.
Xu, Julia, et al.. (2023). Patients, Parents and Providers Perspectives Toward Treatment Options for Sickle Cell Disease. Blood. 142(Supplement 1). 3679–3679. 1 indexed citations
15.
Wang, Xunde, Julia Xu, Anna Conrey, et al.. (2020). Whole genome sequence-based haplotypes reveal a single origin of the 1393 bp HBB deletion. Journal of Medical Genetics. 57(8). 567–570. 6 indexed citations
16.
Xu, Julia & Swee Lay Thein. (2019). The carrier state for sickle cell disease is not completely harmless. Haematologica. 104(6). 1106–1111. 46 indexed citations
17.
Fung, Kin Wah, Julia Xu, S. Trent Rosenbloom, & James R. Campbell. (2019). Using SNOMED CT-encoded problems to improve ICD-10-CM coding—A randomized controlled experiment. International Journal of Medical Informatics. 126. 19–25. 9 indexed citations
18.
McCloskey, Douglas, Julia Xu, Lars Schrübbers, Hanne Bjerre Christensen, & Markus J. Herrgård. (2018). RapidRIP quantifies the intracellular metabolome of 7 industrial strains of E. coli. Metabolic Engineering. 47. 383–392. 24 indexed citations
19.
Xu, Julia, Richard O. Francis, Vaidehi Jobanputra, et al.. (2015). G6PD Deficiency in an HIV Clinic Setting in the Dominican Republic. American Journal of Tropical Medicine and Hygiene. 93(4). 722–729. 6 indexed citations
20.
Geller, James, Zhe He, Yehoshua Perl, C. Paul Morrey, & Julia Xu. (2012). Rule-based support system for multiple UMLS semantic type assignments. Journal of Biomedical Informatics. 46(1). 97–110. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026